Thermo Fisher Scientific offers a uniquely diverse portfolio of genomic solutions across a wide range of technologies, including next-generation sequencing (NGS), real-time PCR, Sanger sequencing, and microarrays. By selecting from our range of solutions and products, we help give you more control over your laboratory now and into the future.
We offer both the tools and expertise to effectively expand your molecular testing menu so you can get fast, accurate, and actionable results with reduced costs per test. Spanning some of the most common disease areas worldwide, our solutions are focused on oncology, infectious disease, reproductive health, inherited disease, and other clinical research tests.
Our collaborative solutions approach helps you meet the evolving molecular testing needs of physicians and patients.
In clinical molecular diagnostics, time is of the essence. Our solutions provide actionable clinical results—accurately and quickly.
Realize reduced per-test costs by developing and running tests that meet the unique needs of your lab, rather than using expensive one-size-fits-all solutions.
In the ever-evolving world of clinical molecular testing, our innovative genomic solutions allow labs to adapt and meet challenges today and tomorrow.
Sanger sequencing and fragment analysis via capillary electrophoresis (CE) are foundational applications used in a range of clinical environments from clinical research, hospital-associated laboratories running molecular assays to larger reference laboratories performing approved in vitro diagnostic assays.
Molecular testing enables accurate results that can enhance the quality of patient care and shape the future for healthcare best practices. Molecular testing has a role in patient management and care decisions across many disease areas including respiratory disease, antibiotic resistance, urinary tract infections, and women’s health.
From carrier screening research to preimplantation genetic testing and prenatal and postnatal applications, our comprehensive portfolio of reproductive health solutions can help you achieve your goals and positively impact families around the world.
End-to-end solutions for lab managers in respiratory, gastrointestinal, urinary tract and vaginal microbiota pathogen detection, and more. Explore our complete menu of flexible-content syndromic solutions and panels.
The Oncomine Dx Target Test* is the first targeted NGS in vitro diagnostic test for non-small cell lung cancer, simultaneously delivering multiple biomarker results for multiple targeted therapies from one sample.
Leverage our comprehensive portfolio to find the right solutions for your lab’s needs. With easy-to-use instruments, intuitive software, and pre-designed assays—from comprehensive NGS panels and whole-genome cytogenetics microarrays to multi-gene CE panels and single-gene assays—we make it simpler for you to obtain relevant oncology results that help you make decisions.
Working closely together with the precision medicine community, Thermo Fisher Scientific is helping advance this revolution in diagnosis and treatment. We leverage our global infrastructure and expertise to provide industry-leading capabilities, from population profiling to targeted therapeutics.
Accurate and trusted IVD solutions for genetic analysis. Our genetic analysis instruments support your lab’s assay development needs along with a workflow to match your clinical diagnostic requirements.
With superior quality and excellent performance, these real-time PCR master mixes are designed to deliver confidence and performance for even your most demanding applications.
For Research Use Only. Not for use in diagnostic procedures.